TY  - GEN
AU  - Leather,Helen
TI  - Economic effects of aspergillosis management in high-risk patients
SN  - 1096-5645
PY  - 2005///0628
KW  - Amphotericin B
KW  - economics
KW  - Antifungal Agents
KW  - Aspergillosis
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Hospitalization
KW  - Humans
KW  - Insurance, Health, Reimbursement
KW  - Pyrimidines
KW  - Triazoles
KW  - United States
KW  - Voriconazole
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ER  -